The increasing prevalence of type 2 diabetes mellitus (T2DM) and associated metabolic complications lead to the development of a syndrome known as “metabolic syndrome” (MetS), which is considered as one of the major risk factor not only for the development of cardiovascular diseases but also have a great impact on the quality of life.
Research Design and Methods
A descriptive, observational study involving the recruitment of patients with T2DM with and without MetS was carried out in outpatient department of endocrinology. The MetS was defined as per the National Cholesterol Education Program–Adult Treatment Panel III (NCEP-ATP III) criteria. Patients with T2DM were screened as per the American Diabetes Association (ADA; ie, fasting blood glucose [FBG] ≥ 126 mg/dL) and who were using oral antidiabetic drugs. Short Form-36 (SF-36) was used to assess the health-related quality of life (HRQoL).
Results:
Patients were grouped as T2DM with MetS (n = 100) and T2DM without MetS (n = 100). A greater significant decline was observed in physical component summary (PCS) and mental component summary (MCS) in patients with T2DM with MetS as compared to patients without MetS (P ≤ .05). Multiple linear regression analysis revealed that in patients with T2DM having MetS, age and waist circumference (WC) are independent predictors for worsening of both PCS and MCS aspects of health-related quality of life (HRQOL). In addition, high triglycerides and raised FBG were found to be correlated with the decline in PCS and MCS, respectively.
Conclusion:
The study demonstrated that patients with T2DM with MetS have overall poor HRQOL as compared to patients with T2DM without MetS.
The Diabetes Atlas. 7th ed. Brussels: International Diabetes Federation2009.
2.
AlbertiKGZimmetPShawJ; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–1062.
3.
UndenALElofssonSAndréassonA, et al.Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. Gend Med. 2008;5(2):162–180.
4.
Martinez-LarradMTCorbaton-AnchueloAFernandez-PerezC, et al.Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population. Diabetes Res Clin Pract. 2016;114:23–31.
5.
ShinJALeeJHLimSY, et al.Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig. 2013;4(4):334–343.
6.
DusejaASinghSPSaraswatVA, et al.Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015;5(1):51–68.
7.
EspositoKChiodiniPColaoA, et al.Metabolic syndrome and risk of cancer. Diabetes care. 2012;35(11):2402–2411.
8.
NsiahKShangVOBoatengKA, et al.Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. Int J Appl Basic Med Res. 2015;5(2):133–138.
9.
YadavDMahajanSSubramanianSK, et al.Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob J Health Sci. 2013;5(6):142–155.
10.
CameronAJShawJEZimmetPZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351–375.
11.
KolovouGDAnagnostopoulouKKSalpeaKD, et al.The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007;333(6):362–367.
12.
DesrochesSLamarcheB. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32(1):23–32.
13.
DeepaMFarooqSDattaM, et al.Prevalence of metabolic syndrome using WHO, ATP III and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–134.
14.
GuptaRDeedwaniaPCGuptaA, et al.Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004;97(2):257–261.
15.
PratyushDDTiwariSSinghS, et al.Risk factors of diabetes in North Indians with metabolic syndrome. Diabetes Metab Syndr. 2016;10(2):S68–S71.
Centers for Disease Control and Prevention Health-Related Quality of Life (HRQOL). http://www.cdc.gov/hrqol/concept.htm. Accessed April 26, 2017.
18.
Asadi-LariMTamburiniMGrayD. Patients’ needs, satisfaction, and health related quality of life: towards a comprehensive model. Health Qual Life Outcomes. 2004;2(1):32.
19.
CampbellSMHannMHackerJ, et al.Identifying predictors of high quality care in English general practice: observational study. BMJ. 2001;323(7316):784–787.
20.
FordESLiC. Metabolic syndrome and health-related quality of life among US adults. Ann Epidemiol. 2008;18(3):165–171.
21.
BanegasJRLópez-GarcíaEGracianiA, et al.Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly. Eur J Cardiovasc Prev Rehabil. 2007;14(3):456–462.
22.
HatamiHDeihimTAmiriP, et al.Association between metabolic syndrome and health-related quality of life among individuals with normal and impaired glucose regulation: findings from Tehran Lipid and Glucose Study. Arch Iran Med. 2016;19(8):577–583.
23.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143.
AmiriPDeihimTTaherianR, et al.Factors affecting gender differences in the association between health-related quality of life and metabolic syndrome components: Tehran Lipid and Glucose Study. PloS One. 2015;10(12):e0143167.
26.
Kazemi-GalougahiMHGhazianiHNArdebiliHE, et al.Quality of life in type 2 diabetes patients and related effective factors. Indian J Med Sci. 2012;66(9-10):230–237.
27.
LaudisioAMarzettiEAntonicaL, et al.Metabolic syndrome and quality of life in the elderly: age and gender differences. Eur J Nutr. 2013;52(1):307–316.
28.
SullivanPWGhushchyanVWyattHR, et al.Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity (Silver Spring). 2007;15(2):511–521.
29.
KatanoSNakamuraYNakamuraA, et al.Relationship between health-related quality of life and clustering of metabolic syndrome diagnostic components. Qual Life Res. 2012;21(7):1165–1170.
30.
TsaiAGWaddenTASarwerDB, et al.Metabolic syndrome and health-related quality of life in obese individuals seeking weight reduction. Obesity. 2008;16(1):59–63.
31.
JahangiryLShojaeezadehDMontazeriA, et al.Health-related quality of life among people participating in a metabolic syndrome e-screening program: a web-based study. Int J Prev Med. 2016;7:27.
32.
WeeHLWuYThumbooJ, et al.Association of body mass index with Short-Form 36 physical and mental component summary scores in a multiethnic Asian population. Int J Obes. 2010;34(6):1034–1043.
33.
YangYHertingJRChoiJ. Obesity, metabolic abnormality, and health-related quality of life by gender: a cross-sectional study in Korean adults. Qual Life Res. 2016;25(6):1537–1548.
34.
KumariMSeemanTMarmotM. Biological predictors of change in functioning in the Whitehall II study. Ann Epidemiol. 2004;14(4):250–257.
35.
VetterMLWaddenTALavenbergJ, et al.Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. Int J Obes. 2011;35(8):1087–1094.
NagpalJKumarAKakarS, et al.The development of ‘Quality of Life Instrument for Indian Diabetes patients (QOLID): a validation and reliability study in middle and higher income groups. J Assoc Physicians India. 2010;58:295–304.
38.
ManjunathKChristopherPGopichandranV, et al.Quality of life of a patient with type 2 diabetes: a cross-sectional study in rural South India. J Family Med Prim Care. 2014;3(4):396–399.
39.
RoyKIyerU. Assessment of quality of life of type 2 diabetes patients with newly diagnosed non alcoholic fatty liver disease using quality of life instrument for Indian diabetes patients. J Soc Health and Diabetes. 2014;2(2):87.
40.
WHOQOL. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551–558.
41.
GohSGRusliBNKhalidBA. Development and validation of the Asian Diabetes Quality of Life (AsianDQOL) Questionnaire. Diabetes Res Clin Pract. 2015;108(3):489–498.
